Tens of thousands of Albertans struggle with effective pain management daily. Managing pain is the most common reason people seek medical attention, and recently, has led to an over-reliance on opioid drugs, with Canada being the second highest consumer of these medications.
The impact of the recent legalization of cannabis has yet to be fully understood. Neuroscientists throughout Alberta are collaborating to research the potential applications of Cannabis use.
The Pain, Cannabis, Opioid program aims to:
- Improve pain management for Albertans
- Inform novel treatment and intervention for pain
- Produce quality research to inform government policy
Campus Alberta Neuroscience is supporting the Alberta Pain Opioid Research Network to encourage collaborative research, improve patient care, train the next generation of pain scientists and clinicians, and shape government and clinical policy in the next three years.
This new network is in the foundational stages and aims to launch within the next year.
Campus Alberta Neuroscience welcomes any industry or research collaborations.
Contact the Pain, Cannabis, Opioid Program
For more information on the Pain, Cannabis, Opioid program, please contact Campus Alberta Neuroscience at (403) 220-2422 or [email protected].